Curis Lifesciences IPO description – Curis Lifesciences is a pharmaceutical manufacturer engaged in producing a diverse range of formulations, including tablets, capsules, oral liquids, external preparations, and sterile ophthalmic ointments. Operating from its WHO-GMP-accredited facility in Sanand GIDC II, Ahmedabad, the company holds two manufacturing licenses—G/25/2225 for general drugs and G/28/1632 for Schedule C, C(1), and X drugs—covering a total of 943 approved products. Its annual installed capacity includes 138 crore tablets, 15.75 crore capsules, 1,080 kilolitres of oral liquids, 270 tons of external preparations, and 45 tons of sterile ophthalmic ointments.
The company operates under three primary business models: Loan License Manufacturing for domestic clients, Contract Manufacturing for merchant exporters and domestic suppliers, and Direct Export/Own Brand Manufacturing in markets such as Yemen and Kenya. As of 31 July 2025, Curis Lifesciences has served over 100 customers and employs 95 permanent staff. While contract and loan license manufacturing contribute the majority of revenues, direct exports represent less than 1%.
The firm’s clientele includes leading pharmaceutical companies such as J.B. Chemicals & Pharmaceuticals, Troikaa Pharmaceuticals, and Centurion Healthcare. Curis Lifesciences continues to expand internationally, leveraging its strategic location, regulatory accreditations, and scalable, customer-driven business model.
Promoters of Curis Lifesciences – Mr. Dharmesh Dashrathbhai Patel, Mr. Siddhant Jayantibhai Pawasia, Mr. Piyush Gordhanbhai Antala, and Mr. Jaimik Mansukhbhai Patel
Table of Contents
Curis Lifesciences IPO Details
| Curis Lifesciences IPO Dates | 7 – 11 November 2025 |
| Curis Lifesciences Issue Price | INR 120 – 128 per share |
| Fresh Issue | 21,50,000 shares (INR 25.80 – 27.52 crore) |
| Offer For Sale | Nil |
| Total IPO Size | 21,50,000 shares (INR 25.80 – 27.52 crore) |
| Minimum Bid | 2,000 shares (INR 2,56,000) |
| Lot Size | 1,000 shares (INR 1,28,000) |
| Face Value | INR 10 per share |
| Retail Allocation | 35% |
| Listing On | NSE EMERGE |
Curis Lifesciences Financial Performance
| FY 2023 | FY 2024 | FY 2025 | 4M FY 2026 | |
| Revenue | 35.45 | 35.56 | 49.13 | 19.50 |
| Expenses | 34.23 | 28.70 | 41.38 | 15.79 |
| Net income | 1.88 | 4.87 | 6.11 | 2.87 |
Curis Lifesciences Offer News
- Curis Lifesciences RHP
- Curis Lifesciences Draft Prospectus
- ASBA IPO Forms
- Live IPO Subscription Status
- Highest SME IPO Subscription in 2025
Curis Lifesciences Valuations & Margins
| FY 2023 | FY 2024 | FY 2025 | |
| EPS | 3.18 | 8.26 | 10.29 |
| PE ratio | – | – | 11.66 – 12.44 |
| RONW (%) | 186.45 | 82.87 | 37.62 |
| NAV | 1.71 | 9.96 | 27.34 |
| ROCE (%) | 14.83 | 33.57 | 27.83 |
| EBITDA (%) | 9.24 | 23.59 | 19.41 |
| Debt/Equity | 16.10 | 2.91 | 0.96 |
Curis Lifesciences IPO GMP Today
| Date | Consolidated IPO GMP | Subject to Sauda |
| 13 November 2025 | 5 | 4,500 |
| 12 November 2025 | 5 | 4,500 |
| 11 November 2025 | 7 | 5,300 |
| 10 November 2025 | 7 | 5,300 |
| 8 November 2025 | 7 | 5,300 |
| 7 November 2025 | 7 | 5,300 |
Curis Lifesciences IPO Subscription – Live Updates
| Category | QIB | NII | Individual | Total |
|---|---|---|---|---|
| Shares Offered | 4,08,000 | 3,09,000 | 7,16,000 | 14,33,000 |
| 11 Nov 2025 | 96.41 | 115.44 | 44.28 | 74.47 |
| 10 Nov 2025 | 8.36 | 4.38 | 3.70 | 5.18 |
| 7 Nov 2025 | 8.36 | 1.19 | 0.84 | 3.06 |
The market maker reservation portion of 1,08,000 shares and the anchor investor portion of 6,09,000 shares are not included in the above calculations.
Curis Lifesciences IPO Allotment Status
Curis Lifesciences IPO allotment status is now available on MUFG Intime’s website. Click this link to get the allotment status.
Curis Lifesciences IPO Dates & Listing Performance
| IPO Opening Date | 7 November 2025 |
| IPO Closing Date | 11 November 2025 |
| Finalization of Basis of Allotment | 12 November 2025 |
| Initiation of refunds | 13 November 2025 |
| Transfer of shares to demat accounts | 13 November 2025 |
| IPO Listing Date | 14 November 2025 |
| Opening Price on NSE SME | INR 146.10 per share (up 14.14%) |
| Closing Price on NSE SME | INR 141 per share (up 10.16%) |
Curis Lifesciences Offer Lead Manager
FINAAX CAPITAL ADVISORS PRIVATE LIMITED
B-401, The First, B/s Keshavbaug Party Plot,
I I M, Ahmedabad-380015, Gujarat, India
Phone: +91 94295 50695 / 9537594321
Email: [email protected]
Website: www.finaaxcapital.com
Curis Lifesciences Offer Registrar
MUFG INTIME INDIA PRIVATE LIMITED
C-101, 1st Floor, 247 Park L.B.S. Marg,
Vikhroli West, Mumbai – 400 083, Maharashtra
Telephone: +91 810 811 4949
Email: [email protected]
Website: www.in.mpms.mufg.com
Curis Lifesciences Contact Details
CURIS LIFESCIENCES LIMITED
PF-23, GIDC Sanand – II, Industrial Estate,
Ahmedabad, Sanand, Gujarat, India, 382110
Phone: +91 99045 22543
E-mail: [email protected]
Website: www.curisls.com
IPO FAQs
What is the Curis Lifesciences offer size?
Curis Lifesciences’ offer size is INR 25.80 – 27.52 crores.
What is the Curis Lifesciences offer price band?
Curis Lifesciences’ public offer price is INR 120 – 128 per share.
What is the lot size of the Curis Lifesciences IPO?
Curis Lifesciences offer lot size is 1,000 shares.
What is the Curis Lifesciences IPO GMP today?
Curis Lifesciences IPO GMP today is INR 5 per share.
What is the Curis Lifesciences kostak rate today?
Curis Lifesciences’ kostak rate today is INR NA per application.
What is the Curis Lifesciences IPO Subject to Sauda rate today?
Curis Lifesciences Subject to Sauda rate today is INR 4,500 per application.